DealBook: GlaxoSmithKline to Make Hostile Bid for Human Genome Sciences

By Vatalyst: It has recently been reported that GlaxoSmithKline (GSK) has lined up alternative candidates to replace the entire board of directors of Human Genome Sciences (HGSI).

LONDON (Reuters) - GlaxoSmithKline will take its $2.6 bil

British drugmaker GlaxoSmithKline on Wednesday said it had gone hostile over its $2.6 billion (2.0 billion-euro) takeover bid for US research partner Human Genome Sciences Inc.GlaxoSmithKline, which in April had an informal offer rejected by the US company's board, said it had decided to put its bid directly to the shareholders of HGS. The offer remains $13 per share in cash."GlaxoSmithKline plc today announced that it will ... commence a tender offer this week to acquire all of the outstanding shares of HGS for $13.0 per share in cash," the British firm said.

British drugmaker GlaxoSmithKline on Wednesday said it had gone hostile over its $2.6 billion (2.0 billion-euro) takeover bid for US research partner Human Genome Sciences Inc.GlaxoSmithKline, which in April had an informal offer rejected by the US company's board, said it had decided to put its bid directly to the shareholders of HGS. The offer remains $13 per share in cash."GlaxoSmithKline plc today announced that it will ... commence a tender offer this week to acquire all of the outstanding shares of HGS for $13.0 per share in cash," the British firm said.

By Proactive Investor: Shares in GlaxoSmithKline (GSK) fell in Wednesday morning trade in London after it went hostile with its bid to acquire the American biotech Human Genome Sciences (HGSI).

VANCOUVER — First Quantum Minerals Ltd. will host a series of investor meetings to pitch its hostile takeover bid directly to Inmet shareholders after the mining company’s board rebuffed the $5.1-billion offer. First Quantum said Inmet’s rejection did not include any compelling alternatives to its proposal and presented only “generic and rehearsed arguments.” The investor meetings will give Inmet shareholders a chance to speak to and hear from members of First Quantum’s senior management team themselves.

(Reuters) - A Maryland judge denied